• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受血液透析的高甘油三酯血症患者中,氯贝丁酯治疗期间脂蛋白脂肪酶增加。

Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.

作者信息

Goldberg A P, Applebaum-Bowden D M, Bierman E L, Hazzard W R, Haas L B, Sherrard D J, Brunzell J D, Huttunen J K, Ehnholm C, Nikkila E A

出版信息

N Engl J Med. 1979 Nov 15;301(20):1073-6. doi: 10.1056/NEJM197911153012001.

DOI:10.1056/NEJM197911153012001
PMID:226883
Abstract

In 11 hypertriglyceridemic patients on hemodialysis, clofibrate (1 to 1.50 g per week) reduced plasma triglyceride (-40 +/- 20%, P less than 0.001), very-low-density-lipoprotein triglyceride (-44 +/- 20%, P less than 0.001) and very-low-density lipoprotein cholesterol (-39 +/- 25%, P less than 0.01), and it increased high-density-lipoprotein cholesterol (82 +/- 106%, P less than 0.005). Low pretreatment lipoprotein-lipase activity in adipose-tissue specimens and postheparin plasma increased to normal with clofibrate, whereas low hepatic triglyceride lipase activity did not change. The reduced very-low-density-lipoprotein triglyceride correlated with the increased lipoprotein-lipase activity in adipose tissue (rs = 0.792, P less than 0.02, n = 8) and postheparin plasma (rs = 0.851, P less than 0.02, n = 8), whereas increased high-density-lipoprotein cholesterol correlated with changes in this activity in adipose tissue (rs = 0.696, P less than 0.06) and post-heparin plasma (rs = 0.679, P less than 0.10). There was no correlation between changes in hepatic triglyceride lipase activity and plasma lipids during treatment. Reduced lipoprotein-lipase activity may cause hypertriglyceridemia and decreased high-density-lipoprotein cholesterol in patients on hemodialysis; clofibrate may correct these abnormalities by increasing lipoprotein-lipase activity to normal.

摘要

在11名接受血液透析的高甘油三酯血症患者中,氯贝丁酯(每周1至1.50克)可降低血浆甘油三酯(-40±20%,P<0.001)、极低密度脂蛋白甘油三酯(-44±20%,P<0.001)和极低密度脂蛋白胆固醇(-39±25%,P<0.01),并增加高密度脂蛋白胆固醇(82±106%,P<0.005)。氯贝丁酯可使脂肪组织标本和肝素后血浆中预处理时较低的脂蛋白脂肪酶活性恢复正常,而肝脏甘油三酯脂肪酶活性较低则无变化。极低密度脂蛋白甘油三酯的降低与脂肪组织(rs=0.792,P<0.02,n=8)和肝素后血浆(rs=0.851,P<0.02,n=8)中脂蛋白脂肪酶活性的增加相关,而高密度脂蛋白胆固醇的增加与脂肪组织(rs=0.696,P<0.06)和肝素后血浆(rs=0.679,P<0.10)中该活性的变化相关。治疗期间肝脏甘油三酯脂肪酶活性的变化与血脂之间无相关性。脂蛋白脂肪酶活性降低可能导致血液透析患者出现高甘油三酯血症和高密度脂蛋白胆固醇降低;氯贝丁酯可能通过将脂蛋白脂肪酶活性提高至正常水平来纠正这些异常情况。

相似文献

1
Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.在接受血液透析的高甘油三酯血症患者中,氯贝丁酯治疗期间脂蛋白脂肪酶增加。
N Engl J Med. 1979 Nov 15;301(20):1073-6. doi: 10.1056/NEJM197911153012001.
2
Selective deficiency of hepatic triglyceride lipase in uremic patients.尿毒症患者肝脏甘油三酯脂肪酶选择性缺乏。
N Engl J Med. 1977 Dec 22;297(25):1362-6. doi: 10.1056/NEJM197712222972502.
3
Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.吉非贝齐:对原发性高甘油三酯血症患者血清脂质、脂蛋白、肝素后血浆脂肪酶活性及葡萄糖耐量的影响
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):58-63. doi: 10.1177/00359157760690S215.
4
High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.甲状腺功能障碍时的高密度脂蛋白胆固醇、肝脂酶及脂蛋白脂酶活性——治疗的影响
Q J Med. 1986 May;59(229):513-21.
5
Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.人体实验性甲状腺功能亢进:对血浆脂蛋白、脂蛋白脂肪酶和肝脂肪酶的影响。
Horm Metab Res. 1983 Sep;15(9):449-52. doi: 10.1055/s-2007-1018751.
6
Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma.氧雄龙治疗对人肝素后血浆中脂蛋白脂肪酶、肝脂肪酶和磷脂酶A1活性的影响。
N Engl J Med. 1975 Jun 19;292(25):1314-7. doi: 10.1056/NEJM197506192922503.
7
Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.血液透析中的脂蛋白改变:糖尿病患者与非糖尿病患者的差异
Metabolism. 2003 Jan;52(1):116-21. doi: 10.1053/meta.2003.50018.
8
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.异维A酸治疗痤疮期间血浆脂质和脂蛋白的变化
N Engl J Med. 1985 Oct 17;313(16):981-5. doi: 10.1056/NEJM198510173131604.
9
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.普伐他汀对血液透析和腹膜透析患者中中间密度脂蛋白的降低作用
Clin Nephrol. 1995 Apr;43(4):268-77.
10
Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.慢性尿毒症患者的脂蛋白代谢。血液透析对血清脂蛋白和肝素后血浆甘油三酯脂肪酶的影响。
Acta Med Scand. 1978;204(3):211-8.

引用本文的文献

1
Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology.持续性乳糜微粒血症的识别与管理:美国国家脂质协会和美国预防心脏病学会联合专家临床共识
Am J Prev Cardiol. 2025 Mar 28;22:100978. doi: 10.1016/j.ajpc.2025.100978. eCollection 2025 Jun.
2
Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis.动脉粥样硬化多族裔研究中与轻度肾功能损害相关的脂蛋白异常
Clin J Am Soc Nephrol. 2008 Jan;3(1):125-32. doi: 10.2215/CJN.03390807. Epub 2007 Dec 5.
3
Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
贝特类药物对人载脂蛋白A-I转基因小鼠中人类与小鼠载脂蛋白A-I的反向调节作用
J Clin Invest. 1996 Jun 1;97(11):2408-16. doi: 10.1172/JCI118687.
4
Disturbances of lipid metabolism in children with chronic renal failure.慢性肾功能衰竭患儿的脂质代谢紊乱
Pediatr Nephrol. 1993 Dec;7(6):749-57. doi: 10.1007/BF01213345.
5
Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.贝特类药物下调载脂蛋白C-III的表达,与过氧化物酶体酰基辅酶A氧化酶的诱导无关。这是贝特类药物降血脂作用的一种潜在机制。
J Clin Invest. 1995 Feb;95(2):705-12. doi: 10.1172/JCI117717.
6
Increase in lipolysis and decrease in plasma-heparin lipoprotein lipase activity and alpha 1 lipoprotein level after aminophylline in man.氨茶碱对人体作用后脂解作用增强,血浆肝素脂蛋白脂肪酶活性及α1脂蛋白水平降低。
Eur J Clin Pharmacol. 1981;19(5):349-51. doi: 10.1007/BF00544585.
7
[Fat and renal failure--therapeutic aspects].[脂肪与肾衰竭——治疗方面]
Klin Wochenschr. 1982 Aug;60(15):761-6. doi: 10.1007/BF01721140.
8
Role of the kidney in hormone metabolism and its implications in clinical medicine.肾脏在激素代谢中的作用及其在临床医学中的意义。
Klin Wochenschr. 1980 Oct 1;58(19):1005-12. doi: 10.1007/BF01476870.
9
[Relation between serum lipoprotein metabolism and biliary lipid metabolism].[血清脂蛋白代谢与胆汁脂质代谢之间的关系]
Klin Wochenschr. 1983 Jun 15;61(12):579-92. doi: 10.1007/BF01487336.
10
Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.氯贝丁酯、苯扎贝特、非诺贝特及普罗布考对血脂正常受试者血浆脂解酶的影响。
Eur J Clin Pharmacol. 1983;25(1):57-63. doi: 10.1007/BF00544015.